JANUS HENDERSON GROUP PLC - VAXCYTE INC ownership

VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 127 filers reported holding VAXCYTE INC in Q3 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.6%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of VAXCYTE INC
ValueSharesWeighting
Q3 2023$359,911,596
+2.1%
7,060,588
+0.0%
0.24%
+7.8%
Q2 2023$352,559,989
+32.0%
7,059,751
-1.0%
0.22%
+24.4%
Q1 2023$267,146,529
-6.7%
7,127,611
+19.3%
0.18%
-14.1%
Q4 2022$286,454,808
+162.8%
5,974,139
-34.2%
0.20%
+150.0%
Q3 2022$109,016,908
+18.6%
9,075,502
+114.8%
0.08%
+30.2%
Q2 2022$91,935,000
-12.1%
4,224,487
-2.4%
0.06%
+26.0%
Q1 2022$104,556,000
+3.5%
4,329,764
+2.0%
0.05%
+19.0%
Q4 2021$101,035,000
-2.7%
4,246,664
+3.7%
0.04%
-6.7%
Q3 2021$103,851,000
+12.1%
4,093,466
-0.6%
0.04%
+12.5%
Q2 2021$92,673,000
+10.9%
4,116,959
-2.7%
0.04%
+5.3%
Q1 2021$83,547,000
-22.3%
4,230,307
+0.8%
0.04%
-24.0%
Q4 2020$107,538,000
-46.2%
4,196,778
+0.0%
0.05%
-51.9%
Q3 2020$199,839,000
+42.8%
4,196,429
-11.2%
0.10%
+31.6%
Q2 2020$139,934,0004,725,7920.08%
Other shareholders
VAXCYTE INC shareholders Q3 2022
NameSharesValueWeighting ↓
Abingworth LLP 4,168,718$90,711,00029.04%
Medicxi Ventures Management (Jersey) Ltd 3,774,956$82,142,00017.06%
Pivotal bioVenture Partners Investment Advisor LLC 832,166$18,108,0009.12%
GREAT POINT PARTNERS LLC 985,153$21,437,0005.14%
Kynam Capital Management, LP 723,781$15,749,0004.02%
Ghost Tree Capital, LLC 325,000$7,072,0003.68%
Frazier Life Sciences Management, L.P. 1,787,405$38,894,0003.67%
RA Capital Management 4,581,203$99,687,0002.66%
Opaleye Management Inc. 190,000$4,134,0001.86%
Soleus Capital Management, L.P. 370,650$8,065,0001.26%
View complete list of VAXCYTE INC shareholders